L. Aponte Becerra

Safety of Intranasal Insulin in Type 2 Diabetes on Systemic Insulin: A Double-Blinded Placebo-Controlled Sub-Study of Memaid Trial

V. Lioutas, C. Mantzoros, P. Novak, 2022, Archives of diabetes & obesity.

MemAID: Memory advancement with intranasal insulin vs. placebo in type 2 diabetes and control participants: a randomized clinical trial

C. Mantzoros, P. Novak, V. Lioutas, 2022, Journal of Neurology.

Depressive symptoms exacerbate disability in older adults: A prospective cohort analysis of participants in the MemAID trial

L. Ngo, C. Fortier, S. Buss, 2022, PloS one.